FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1546-1547 May 21, 1998 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bartalena, L. Related Article by Bartalena, L. PubMed Citation

To the Editor: The article by Bartalena et al. (Jan. 8 issue)¹ on therapy for hyperthyroidism and Graves' ophthalmopathy could be important in establishing practice precedents. Clarification of the following points is needed to define more fully the inferences readers can draw from the findings.

We think the authors should have carried out an intention-to-treat analysis of the results at one year in all patients in each group. Instead, in Table 3, the data in subgroups of patients who had no change, worsening, or improvement are shown separately. Comparisons are then made within these selected subgroups. This approach violates a . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Bartalena, L., Pinchera, A., Marcocci, C. (2000). Management of Graves' Ophthalmopathy: Reality and Perspectives. Endocr. Rev. 21: 168-199 [Abstract] [Full Text]